ADVFN US – Market Content Editor
-

Hoth Therapeutics gains after winning China patent for HT-KIT cancer program
Shares of Hoth Therapeutics Inc (NASDAQ:HOTH) advanced 3.6% in premarket trading on Wednesday after the clinical-stage biopharmaceutical company said it has been granted an important patent in China related to its HT-KIT oncology program. The patent was approved by the China National Intellectual Property Administration and covers Hoth’s HT-KIT technology, which is designed to trigger…
-

Lucid Diagnostics jumps after landing VA agreement for EsoGuard cancer screening
Shares of Lucid Diagnostics Inc (NASDAQ:LUCD) rose 12.4% in premarket trading on Wednesday after the company said it had won a contract with the U.S. Department of Veterans Affairs (VA) covering its EsoGuard Esophageal DNA Test. The deal broadens access to Lucid’s esophageal precancer screening across the VA’s nationwide healthcare network, which provides care to…
-

Lisata Therapeutics surges on Kuva Labs takeover proposal carrying hefty premium
Shares of Lisata Therapeutics Inc (NASDAQ:LSTA) jumped nearly 85% in premarket trading on Wednesday after the clinical-stage drug developer said it has signed a binding term sheet to be acquired by privately held Kuva Labs, Inc. Under the proposed deal, Kuva Labs plans to launch a tender offer to acquire all outstanding Lisata shares for…
-

Nathan’s Famous jumps after Smithfield Foods tables $102-a-share takeover bid
Shares of Nathan’s Famous Inc (NASDAQ:NATH) surged 9.6% in premarket trading on Wednesday after Smithfield Foods Inc (NASDAQ:SFD) unveiled an all-cash proposal to buy the hot dog brand for $102.00 per share. The transaction places an enterprise value of roughly $450 million on Nathan’s Famous and would give Smithfield permanent ownership of the brand, which…
-

Ocugen shares slide after company prices $22.5 million equity raise
Shares of Ocugen, Inc. (NASDAQ:OCGN) fell 6.6% in premarket trading on Wednesday after the biotech group announced the pricing of an underwritten common stock offering. Ocugen said it will issue 15 million common shares at a price of $1.50 per share, with the transaction expected to raise $22.5 million in gross proceeds before underwriting fees…
-

Prologis shares climb after Q4 results beat forecasts on robust leasing demand
Prologis Inc. (NYSE:PLD) reported fourth-quarter profit and revenue that topped Wall Street expectations on Wednesday, supported by solid leasing activity across its global warehouse portfolio, as the industrial REIT enters 2026 with upbeat earnings guidance. The shares rose 2.37% in premarket trading. Prologis, a roughly $123 billion industrial real estate investment trust, has continued to…
-

Aqua Metals shares jump on multi-year supply pact with 6K Energy
Shares of Aqua Metals, Inc. (NASDAQ:AQMS) climbed about 20% after the sustainable battery metals recycler announced it had entered into a multi-year Material Supply Agreement (MSA) with 6K Energy, a U.S. manufacturer of advanced cathode active materials. The agreement outlines a framework under which Aqua Metals will supply battery-grade nickel metal and lithium carbonate produced…
-

U.S. equities set for potential further losses at the open: Dow Jones, S&P, Nasdaq, Wall Street Futures
U.S. stock index futures are signaling a slightly weaker start to Wednesday’s session, pointing to the possibility of additional declines after the sharp sell-off seen a day earlier. Investor sentiment remains fragile amid fears of an escalating trade dispute between the United States and Europe, sparked by President Donald Trump’s push to secure control of…
-

Ally Financial slides as investors zero in on softness in auto lending
Ally Financial Inc. (NYSE:ALLY) reported fourth-quarter adjusted earnings that came in ahead of expectations on Wednesday, but its shares moved lower as investors focused on continued pressure in the company’s auto finance business. The stock fell 3.35% in premarket trading following the results. The digital bank and auto lender posted adjusted earnings per share of…
-

Charles Schwab posts in-line Q4 earnings as shares slide despite record revenue
The Charles Schwab Corporation (NYSE:SCHW) reported fourth-quarter results that met market expectations, but its shares fell about 3% as investors reacted cautiously to the broadly in-line performance, even as revenue hit a new record. The group delivered adjusted earnings per share of $1.39 for the quarter, exactly matching analyst forecasts. Revenue came in at a…